Press Releases

NEW HAVEN, Conn., Aug. 8, 2019 /PRNewswire/ -- Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN, the "Company"), a clinical-stage biopharmaceutical company with a portfolio of innovative, late-stage product candidates targeting neurological and neuropsychiatric diseases, today reported financial results for the quarter ended June 30, 2019, and prov

Read more...

SYDNEY, Aug. 9, 2019 /PRNewswire/ -- The iQ Group Global is honoured to be recognised as one of Australia and New Zealand's Top 5 Most Innovative Companies by The Australian Financial Review and BOSS Magazine in its r

Read more...

SMITHS FALLS, ON, Aug. 9, 2019 /PRNewswire/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED), (NYSE: CGC) is pleased to announce that it has entered into an agreement to acquire the global cannabinoid-based medical researcher Beckley Canopy Therapeutics ("Beckley Canopy"). The acquisition brings together Canopy's wholly owned research progr

Read more...

BROOMFIELD, Colo., Aug. 9, 2019 /PRNewswire/ -- A multidisciplinary/interdisciplinary group of orthobiologics experts from the fields of orthopedic surgery, sports medicine, physical medicine and rehabilitation, pain medicine, and interventional spine have embarked on a Delphi panel process to set treatment standards for patients receiving a same day stem cell proce

Read more...

STOCKHOLM, Aug. 9, 2019 /PRNewswire/ -- OssDsign AB (publ) ("OssDsign" or the "Company"), the Swedish designer and manufacturer of innovative implants for bone regeneration, has filed for a Japanese regulatory approval of OssDsign Cranial. Subsequent to the filing, OssDsign initiates commercial planning for a market entry in Japan.

Read more...

NEW YORK and SYDNEY, Aug. 9, 2019 /PRNewswire/ -- EnGeneIC Limited, a clinical-stage biopharmaceutical company advancing its pro

Read more...

NEW YORK, Aug. 8, 2019 /PRNewswire/ -- Bragar Eagel & Squire, P.C. is investigating potential claims against Novartis AG (NASDAQ: NVS) on behalf of Novartis investors. Our investigation concerns whether Novartis has violated the federal securities laws and/or engaged in other unlawful business practices.

Read more...

LOS ANGELES, Aug. 8, 2019 /PRNewswire/ -- Adnant, an accounting and consulting firm, is hosting a networking event at Outside Lands that will bring together top cannabis brands, executives and investors. Outside Lands takes place in San Francisco's Golden Gate Park from August 9-11, 2019. The festival is

Read more...

NEW YORK, Aug. 8, 2019 /PRNewswire/ -- Bragar Eagel & Squire, P.C. is investigating potential claims against the board of directors of Corindus Vascular Robotics, Inc. (NYSE: CVRS) on behalf of Corindus shareholders concerning the proposed merger with a subsidiary of Siemens Healthineers AG.

Read more...

CHICAGO, Aug. 8, 2019 /PRNewswire/ -- Gun violence in the United States is a public health crisis and should be addressed much as the government studies motor vehicle deaths, according to the president of the American Psychological Association.

Read more...